The US Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic test for chlamydia, gonorrhea, and trichomoniasis in women.
The FDA has approved a new at-home test for common sexually transmitted infections and diseases. The test for chlamydia, ...
The U.S. Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic ...
The FDA has approved the first at-home, nonprescription test for chlamydia, gonorrhea, and trichomoniasis in women. The Visby ...
For all treated chlamydia infections, 14.0% of patients received doxycycline—the CDC's recommended treatment—alone or with ...
Shiying Hao, Ph.D., from Stanford University in California, and colleagues used electronic health records to identify ...
Health and Me on MSN5 天
FDA Approves At-Home Test For Three STIs In WomenThe US Food and Drug Administration has approved a single-use at-home test which can detect three STIs in women. Read on to ...
The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway for more to come.
The FDA on Friday granted marketing authorization to the first at-home test for diagnosing chlamydia, gonorrhea, and ...
12 天
GlobalData on MSNFDA fast tracks Sanofi’s mRNA vaccine for chlamydiaWith our programme, we aim to make chlamydia a preventable disease through vaccination.” A separate vaccine candidate has ...
Shiying Hao, PhD, from Stanford University in California, and colleagues used electronic health records to identify patients with diagnosis codes or positive test results for chlamydia and/or ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果